The determinants of pharmaceutical R&D expenditures: Evidence from Japan

Review of Industrial Organization

Volumn 28, Issue 2, 2006, Pages 145-164

  Mahlich, Jörg C ^a   Roediger Schluga, Thomas ^b  

^a Austrian Federal Economic Chamber   (Austria)

^b AIT AUSTRIAN INSTITUTE OF TECHNOLOGY   (Austria)

Author keywords

Investment; Japan; Panel data estimation; Pharmaceuticals; R D

Indexed keywords

EXPENDITURE; PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT;

ASIA; EURASIA; FAR EAST; JAPAN;

EID: 33645060477     PISSN: 0889938X     EISSN: 15737160     Source Type: Journal    
DOI: 10.1007/s11151-006-0010-z     Document Type: Article

References (41)

1. Z. J. Acs D. B. Audretsch 1991 Innovation and Technological Change: An International Comparison Basil Blackwell Oxford
2. G. A. Akerlof 1970 'The Market for "Lemons": Quality, Uncertainty and the Market Mechanism' Quarterly Journal of Economics 84 488-500
3. M. Arellano S. R. Bond 1991 'Some Tests of Specification for Panel Data: Monte Carlo Evidence and An Application to Employment Equations' Review of Economic Studies 58 277-297
4. B. H. Baltagi P. X. Wu 1999 'Unequally Spaced Panel Data Regressions with AR(1) Disturbances' Econometric Theory 15 814-823 10.1017/ S0266466699156020
5. R. W. Blundell S. R. Bond 1998 'Initial Conditions and Moment Restrictions in Dynamic Panel Data Models' Journal of Econometrics 87 115-143 10.1016/S0304-4076(98)00009-8
6. Bond S., Harhoff D., and J. Van Reenen (2003) Investment, R&D, and Financial Constraints in Britain and Germany. Centre for Economic Performance, LSE, CEP Discussion Paper, 0595.
7. S. R. Bond 2002 'Dynamic Panel Data Models: A Guide to Micro Data Methods and Practice' Portuguese Economic Journal 1 141-162 10.1007/ s10258-002-0009-9 (also available as cemmap Working Paper, CWP09/02)
8. W. M. Cohen 1995 'Empirical Studies of Innovative Activity' P. Stoneman Handbook of the Economics of Innovation and Technological Change Blackwell Oxford 182-264
9. W. M. Cohen D. Levinthal 1990 'Absorptive Capacity: A New Perspective on Learning and Innovation' Administrative Science Quarterly 35 128-152
10. (reprinted in Mansfield E. and Mansfield E. (eds.), (1993), The Economics of Technical Change, Edward Elgar: Aldershot, UK and Brookfield, US, 458-85)
11. W. M. Cohen D. Levinthal 1989 'Innovation and Learning: The Two Faces of R&D' Economic Journal 99 569-596
12. (reprinted in Mansfield E. and Mansfield E. (eds.), (1993), The Economics of Technical Change, Edward Elgar: Aldershot, UK and Brookfield, US, 458-85)
13. H. G. Grabowski J. M. Vernon 2000 'The Determinants of Pharmaceutical Research and Development Expenditures' Journal of Evolutionary Economics 10 201-215 10.1007/s001910050012
14. H. G. Grabowski J. M. Vernon 1994 'Return to R&D in New Drug Introductions in the 80's' Journal of Health Economics 13 383-406 10.1016/0167-6296(94)90010-8
15. Griliches Z., and J. Mairesse (1990) 'R&D and Productivity Growth: Comparing Japanese and US Manufacturing Firms' in C. Hulten (ed.), Productivity Growth in Japan and the United States. Chicago, pp. 317-348.
16. K. Gugler D. C. Mueller B. B. Yurtoglu 2003 'Marginal q, Tobin's q, Cash Flow and Investment' Southern Economic Journal 70 512-531
17. B. H. Hall 2002 'The Financing of Research and Development' Oxford Review of Economic Policy 18 35-51
18. Hall B. H. (1992) Investment and Research and Development at the Firm Level: Does the Source of Financing Matter. NBER Working paper, no. 4096, NBER: Cambridge, MA.
19. B. H. Hall J. Mairesse L. Branstetter B. Crépon 1999 'Does Cash Flow Cause Investment and R&D: An Exploration Using Panel Data for French, Japanese and United State Firms in the Scientific Sector' D. Audretsch R.R. Thurik Innovation, Industry Evolution and Employment Cambridge University Press Cambridge
20. R. M. Henderson I. Cockburn 1996 'Scale, Scope and Spillovers: The determinants of Research Productivity in Drug Discovery' RAND Journal of Economics 27 32-59
21. A. Hisashige 1997 'Healthcare Technology Assessment and the Challenge to Pharmaeconomics in Japan' PharmacoEconomics 11 319-333
22. T. Hoshi A. K. Kashyap 2001 Corporate Financing and Governance in Japan MIT Press Cambridge, MA
23. T. Hoshi A. Kashyap D. Scharfstein 1991 'Corporate Structure, Liquidity and Investment: Evidence from Japanese Panel Data' Quarterly Journal of Economics 100 33-60
24. R. G. Hubbard 1998 'Capital-Market Imperfections and Investment' Journal of Economic Literature 26 193-225
25. C. Huttin 1995 'The Japanese Drug Price Policy: A New Dynamic on Price Competition' Journal of Research in Pharmaceutical Economics 4 21-34
26. IMS HEALTH (2003) IMS World Review 2003. Fairfield, CT.
27. Koseisho [Ministry of Health and Welfare] (1996) Kazoku to shakai hosho- kazoku no shakai-teki shien no tame ni [Family and Social Insurance]. Tokyo.
28. M. McLellan 1997 'A Turning Point in Japanese Sales Promotion' Scrip Magazine 10 25-27
29. Miarka T. (1999) 'The Recent Economic Role of Bank-firm Relationships in Japan'. WZB Discussion Paper, FS IV 99-36.
30. Morgan Stanley Dean Witter (1998) Japan Investment Research: Japan Pharmaceuticals. Tokyo.
31. B. Mulkay B. H. Hall J. Mairesse 2001 'Investment and R&D in France and in the United State' D. Bundesbank Investing Today for the World of Tomorrow Springer Berlin, Heidelberg and New York
32. OECD 2001 Science, Technology and Industry Scoreboard 2001 OECD Paris
33. A. J. Oliver N. Ikegami S. Ikeda 1997 'Japan's Aging Population - Implications for Healthcare' PharmacoEconomics 11 306-318
34. PhRMA (2003) Industry Profile. Washington, D.C.
35. PhRMA (1999) Industry Profile. Washington, D.C.
36. M. R. Reich 1990 'Why the Japanese don't Export More Pharmaceuticals: Health Policy as Industrial Policy' California Management Review 32 124-150
37. F. M. Scherer D. Harhoff J. Kukies 2000 'Uncertainty and the Size Distribution of Rewards from Innovation' Journal of Evolutionary Economics 10 175-200 10.1007/s001910050011
38. M. Sharp P. Patel 1997 'Europe's Pharmaceutical Industry: An Innovation Profile' A. Arundel R. Garrelfs Innovation Measurement and Policies European Commission Luxembourg
39. Silverberg G., and B. Verspagen (2005) 'The Size Distribution of Innovations Revisited: An Application of Extreme Value Statistics to Citation and Value Measures of Patent Significance', Journal of Econometrics, (forthcoming).
40. L. G. Thomas 2001 The Japanese Pharmaceutical Industry: The New Drug Law and the Failure of Industrial Policy Edward Elgar Cheltenham, UK and Northampton, MA, US
41. A. Tylecote 1994 'Financial Systems and Innovation' M. Dodgson R. Rothwell The Handbook of Industrial Innovation Edward Elgar Aldershot, UK and Brookfield, US 259-267